Jaguar Health, Inc. (JAGX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.250 -- 00:00:06.217 Greetings and welcome to Jaguar Health's May 15, 2025 investor webcast. 00:00:06.217 -- 00:00:10.783 Before I turn the call over to management, I'd like to remind you that management may 00:00:10.783 -- 00:00:15.929 look forward to looking at statements relating to such matters as continued growth prospects 00:00:15.929 -- 00:00:21.155 for the company, uncertainties regarding market acceptance of products, 00:00:21.155 -- 00:00:26.362 the impact of competitive products and pricing, industry trends, and product 00:00:26.362 -- 00:00:31.496 initiatives, including products in the development stage, which may not achieve scientific 00:00:31.496 -- 00:00:35.101 objectives or meet stringent regulatory 00:00:35.101 -- 00:00:36.803 requirements. 00:00:36.803 -- 00:00:40.929 Forward-looking statements are subject to risk and uncertainties that could cause actual 00:00:40.929 -- 00:00:46.616 results to differ materially from those contemplated in such forward-looking statements. 00:00:46.616 -- 00:00:51.583 These statements are based on currently available information and management current 00:00:51.583 -- 00:00:57.203 assumptions, expectations, and projections about future events. 00:00:57.203 -- 00:01:02.449 While management believes its assumptions, expectations, and projections are reasonable 00:01:02.449 -- 00:01:07.935 in view of currently available information, you are cautioned not to place undue reliance 00:01:07.935 -- 00:01:10.338 on these forward-looking statements. 00:01:10.338 -- 00:01:15.544 The company's actual results may differ materially from those discussed during this webcast 00:01:15.544 -- 00:01:20.690 for a variety of reasons, including those described in the forward-looking statements 00:01:20.690 -- 00:01:26.617 and...